[由门胆病症复杂的非肝性门脉高血压]
S V Mikhin1, P V Mozgovoy1, V V Mandrikov1
1Volgograd State Medical University, Volgograd, Russia.
Khirurgiia
|February 20, 2026
概括
机械黄在非脊髓硬化门腔高血压 (NCPH) 中可能导致门腔高血压胆病变 (PHB). 本研究回顾了症状性PHB的管理策略,PHB是一种罕见但严重的并发症.
科学领域:
- 胃肠病学 胃肠病学
- 肝病学 肝病学是一种肝病学.
- 胆道医学 胆道医学
背景情况:
- 非性门高血压 (NCPH) 与机械黄有关.
- 门高血压胆病变 (PHB) 是一种术语,用于描述PH的胆道问题.
- 在NCPH (81-100%) 中,PHB的发生率明显高于肝脏阻塞 (0-33%).
研究的目的:
- 审查关于门性高血压胆病变 (PHB) 的文献.
- 讨论NCPH患者的症状PHB的管理.
- 介绍PHB并发症的临床病例和治疗方案.
主要方法:
- 关于PHB和NCPH的文献综述.
- 对PHB临床表现的分析.
- 在PHB和机械黄患者的病例系列中.
主要成果:
- 无症状PHB在NCPH患者中非常普遍.
- 症状PHB发生在少数 (5-33%) 的NCPH患者中.
- 在PHB患者的胆道干预过程中,由于凝血病,存在风险.
结论:
- 对于症状性PHB的最佳治疗方法缺乏共识.
- 治疗PHB需要仔细考虑凝血病风险.
- 需要进一步的研究来制定症状PHB的治疗指南.
相关概念视频
Hepatic Portal System
6.5K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.5K
Esophageal Varices-II: Clinical Features and Management
647
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
647
Esophageal Varices-I: Introduction
1.6K
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.6K
Diseases of the Liver and Gallbladder
2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
223
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
223
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
270
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
270


